1. Home
  2. FATE vs FISI Comparison

FATE vs FISI Comparison

Compare FATE & FISI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FATE
  • FISI
  • Stock Information
  • Founded
  • FATE 2007
  • FISI 1817
  • Country
  • FATE United States
  • FISI United States
  • Employees
  • FATE N/A
  • FISI N/A
  • Industry
  • FATE Biotechnology: Biological Products (No Diagnostic Substances)
  • FISI Major Banks
  • Sector
  • FATE Health Care
  • FISI Finance
  • Exchange
  • FATE Nasdaq
  • FISI Nasdaq
  • Market Cap
  • FATE 406.5M
  • FISI 416.6M
  • IPO Year
  • FATE 2013
  • FISI 1999
  • Fundamental
  • Price
  • FATE $1.27
  • FISI $26.97
  • Analyst Decision
  • FATE Hold
  • FISI Hold
  • Analyst Count
  • FATE 10
  • FISI 3
  • Target Price
  • FATE $6.75
  • FISI $26.67
  • AVG Volume (30 Days)
  • FATE 3.2M
  • FISI 131.4K
  • Earning Date
  • FATE 02-24-2025
  • FISI 01-30-2025
  • Dividend Yield
  • FATE N/A
  • FISI 4.45%
  • EPS Growth
  • FATE N/A
  • FISI N/A
  • EPS
  • FATE N/A
  • FISI 3.17
  • Revenue
  • FATE $13,447,000.00
  • FISI $216,605,000.00
  • Revenue This Year
  • FATE N/A
  • FISI N/A
  • Revenue Next Year
  • FATE N/A
  • FISI $18.29
  • P/E Ratio
  • FATE N/A
  • FISI $8.50
  • Revenue Growth
  • FATE N/A
  • FISI 9.25
  • 52 Week Low
  • FATE $1.04
  • FISI $16.29
  • 52 Week High
  • FATE $8.83
  • FISI $29.34
  • Technical
  • Relative Strength Index (RSI)
  • FATE 31.94
  • FISI 51.43
  • Support Level
  • FATE $1.22
  • FISI $26.40
  • Resistance Level
  • FATE $1.36
  • FISI $27.50
  • Average True Range (ATR)
  • FATE 0.15
  • FISI 0.70
  • MACD
  • FATE -0.02
  • FISI -0.00
  • Stochastic Oscillator
  • FATE 24.21
  • FISI 66.16

About FATE Fate Therapeutics Inc.

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

About FISI Financial Institutions Inc.

Financial Institutions Inc operates as a financial holding company, engages in the provision of a wide range of consumer and commercial banking services to individuals, municipalities, and businesses in Western and Central New York. It operates through one segment: The Banking segment which includes all of the company's retail and commercial banking operations.

Share on Social Networks: